Cannara Biotech Stock Analysis

Cannara OTC Stock Analysis Notes

About 48.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Cannara Biotech had not issued any dividends in recent years. The entity had 1:10 split on the 13th of February 2023. Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada. Cannara Biotech is traded on OTC Exchange in the United States.The quote for Cannara Biotech is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Cannara Biotech contact Zohar Krivorot at 514 543 4200 or learn more at https://cannara.ca.

Cannara Biotech Investment Alerts

Cannara Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 63.27 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cannara Biotech's market, we take the total number of its shares issued and multiply it by Cannara Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Cannara Profitablity

The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.

Technical Drivers

As of the 2nd of February, Cannara Biotech shows the Risk Adjusted Performance of 0.1347, mean deviation of 3.48, and Downside Deviation of 7.41. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cannara Biotech, as well as the relationship between them. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Cannara Biotech, which can be compared to its peers. Please confirm Cannara Biotech treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Cannara Biotech is priced correctly, providing market reflects its regular price of 0.75 per share. As Cannara Biotech is a penny stock we also strongly suggest to validate its total risk alpha numbers.

Cannara Biotech Price Movement Analysis

Cannara Biotech Predictive Daily Indicators

Cannara Biotech Forecast Models

Cannara Biotech's time-series forecasting models are one of many Cannara Biotech's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cannara Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Cannara Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cannara shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Cannara Biotech. By using and applying Cannara OTC Stock analysis, traders can create a robust methodology for identifying Cannara entry and exit points for their positions.

When running Cannara Biotech's price analysis, check to measure Cannara Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cannara Biotech is operating at the current time. Most of Cannara Biotech's value examination focuses on studying past and present price action to predict the probability of Cannara Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cannara Biotech's price. Additionally, you may evaluate how the addition of Cannara Biotech to your portfolios can decrease your overall portfolio volatility.